Blood Donation From Warfarin Users for the Development of POC INR Monitor
NCT02355730 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1560
Last updated 2015-02-04
Summary
This study is to further develop and optimise the design and manufacturing process of a handheld device to monitor and manage Warfarin (blood thinning anticoagulation drug) therapy. The device comprises of a handheld instrument and a disposable test strip and reports how blood coagulation is working in terms of standardised units called International Normalised Ratio (INR). A single drop of fresh whole blood and plasma will be added to the strip and the INR result displayed on the instrument. Blood samples are to be collected from patients attending a hospital based INR clinic who are on Warfarin Therapy. The samples are to be used in a series of experiments in the laboratory to test the Microvisk POC INR Monitors accuracy, precision, stability and robustness.
Conditions
- Atrial Fibrillation
- Pulmonary Embolism
- Deep Vein Thrombosis
Interventions
- PROCEDURE
-
Venepuncture
Venepuncture to collect blood samples from Patients undergoing Warfarin Therapy.
Sponsors & Collaborators
-
Microvisk Technologies Ltd
lead INDUSTRY
Principal Investigators
-
Cheng-Hock Toh, Professor · Royal Liverpool and Broadgreen University Hospital Trust
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-05-31
- Primary Completion
- 2016-05-31
- Completion
- 2016-06-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Patient Self Testing of Warfarin Therapy
NCT00594828 ·Status: UNKNOWN ·Phase: PHASE4
-
Use of Activated Recombinant Human Factor VII to Reduce Bleeding Caused by Warfarin Treatment
NCT01561937 ·Status: COMPLETED ·Phase: PHASE1
-
Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients
NCT00814177 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Thrombotic Status in Patients With Acute Coronary Syndrome
NCT02562690 ·Status: UNKNOWN
-
International Normalised Ratio Evaluation by Generalist Practitioners in Full-time Care Establishments for the Elderly
NCT02614573 ·Status: COMPLETED ·Phase: NA
-
Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT
NCT01006733 ·Status: COMPLETED ·Phase: PHASE3
-
Assessing the Ability of Warfarin Treated Patients to Predict Their INR
NCT02764112 ·Status: COMPLETED
-
Accuracy of a Portable International Normalized Ratio Monitor in Elderly Patients
NCT01930916 ·Status: UNKNOWN ·Phase: NA
-
Warfarin - How Good Are we at Maintaining Target Range ?
NCT01081327 ·Status: COMPLETED
-
Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) Monitoring System With New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity
NCT01037270 ·Status: COMPLETED
-
The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR
NCT00247702 ·Status: UNKNOWN ·Phase: NA
-
Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 2
NCT02371070 ·Status: COMPLETED
-
The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT
NCT02376803 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients
NCT02592980 ·Status: UNKNOWN ·Phase: PHASE4
-
INR at Home Measurement by the LabPad® Point-of-care in Patients on Vitamin K Antagonist Drugs (VKA)
NCT04117048 ·Status: COMPLETED ·Phase: NA
-
To Establish a Novel Prototype of Clinical Pharmacy Services by Warfarin Consultation in a Pharmacist Clinic
NCT01972971 ·Status: UNKNOWN ·Phase: NA
-
Subtherapeutic INR Levels in Patients With AVK: Incidence, Associated Factors, Prognosis and Control Strategies
NCT02610153 ·Status: COMPLETED
-
Remote Home Prothrombin Time (PT)/International Normalized Ratio (INR) Monitoring and Patient Management System
NCT00978445 ·Status: COMPLETED ·Phase: NA
-
A Performance Evaluation of the LumiraDx Point Of Care D-dimer Assay
NCT04737954 ·Status: UNKNOWN ·Phase: NA
-
Improved Time in Therapeutic Range With Patient Self-Testing of Their INR Compared to Usual Care
NCT00703963 ·Status: COMPLETED ·Phase: NA
-
Direct Oral Anticoagulants and Venous Thromboembolism
NCT02833987 ·Status: COMPLETED
-
Pharmacogentic Screening of Coumarine Based Oral Anticoagulant Using Next Generation Seguencer
NCT03180567 ·Status: UNKNOWN ·Phase: NA
-
PRospective Evaluation Comparing Initiation of Warfarin StrategiEs (PRECISE): Pharmacogenetic-guided Versus Usual Care
NCT00377143 ·Status: WITHDRAWN ·Phase: PHASE4
-
Point-of-Care Testing (POCT) for Guided Precision Anticoagulation With Warfarin: A Multicenter, Non-concurrent Controlled Study
NCT06645275 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Evaluation of the Accuracy of the INRatio Prothrombin Time (PT) Monitoring System With a New Test Strip for the Oral Anticoagulation Therapy Patient in the Presence of Heparin and Low Molecular Weight Heparin (e.g., Enoxaparin or Dalteparin)
NCT00933738 ·Status: COMPLETED